Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Understanding Heart Conditions
 Heart Disease Q&A
 Heart Disease Symptoms
 Quiz: Your Heart Health IQ
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Epogen

[Epoetin alfa]


Overdosage & Contraindications
CONTRAINDICATIONS

EPOGEN (r) is contraindicated in patients with:
1. Uncontrolled hypertension.
2. Known hypersensitivity to mammalian cell-derived products.
3. Known hypersensitivity to Albumin (Human).


OVERDOSAGE

Text Continues Below



The maximum amount of EPOGEN (r) that can be safely administered in single or multiple doses has not been determined. Doses of up to 1500 Units/ kg TIW for 3 to 4 weeks have been administered to adults without any direct toxic effects of EPOGEN (r) itself.

Therapy with EPOGEN (r) can result in polycythemia if the hematocrit is not carefully monitored and the dose appropriately adjusted. If the suggested target range is exceeded, EPOGEN (r) may be temporarily withheld until the hematocrit returns to the suggested target range; EPOGEN (r) therapy may then be resumed using a lower dose (see DOSAGE AND ADMINISTRATION). If polycythemia is of concern, phlebotomy may be indicated to decrease the hematocrit.










About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service    
Advertising Policy